A citation-based method for searching scientific literature

Ylenia Lombardo, Monica Faronato, Aleksandra Filipovic, Valentina Vircillo, Luca Magnani, R Charles Coombes. Breast Cancer Res 2014
Times Cited: 48







List of co-cited articles
699 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
Bruno M Simões, Ciara S O'Brien, Rachel Eyre, Andreia Silva, Ling Yu, Aida Sarmiento-Castro, Denis G Alférez, Kath Spence, Angélica Santiago-Gómez, Francesca Chemi,[...]. Cell Rep 2015
124
39

Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.
Hannah Harrison, Gillian Farnie, Sacha J Howell, Rebecca E Rock, Spyros Stylianou, Keith R Brennan, Nigel J Bundred, Robert B Clarke. Cancer Res 2010
378
27

Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells.
J Yun, A Pannuti, I Espinoza, H Zhu, C Hicks, X Zhu, M Caskey, P Rizzo, G D'Souza, K Backus,[...]. Oncogenesis 2013
50
27

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
Chad J Creighton, Xiaoxian Li, Melissa Landis, J Michael Dixon, Veronique M Neumeister, Ashley Sjolund, David L Rimm, Helen Wong, Angel Rodriguez, Jason I Herschkowitz,[...]. Proc Natl Acad Sci U S A 2009
20

Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.
Pasquale Sansone, Claudio Ceccarelli, Marjan Berishaj, Qing Chang, Vinagolu K Rajasekhar, Fabiana Perna, Robert L Bowman, Michele Vidone, Laura Daly, Jennifer Nnoli,[...]. Nat Commun 2016
118
20

The epithelial-mesenchymal transition generates cells with properties of stem cells.
Sendurai A Mani, Wenjun Guo, Mai-Jing Liao, Elinor Ng Eaton, Ayyakkannu Ayyanan, Alicia Y Zhou, Mary Brooks, Ferenc Reinhard, Cheng Cheng Zhang, Michail Shipitsin,[...]. Cell 2008
18

Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer.
Luca Magnani, Alexander Stoeck, Xiaoyang Zhang, András Lánczky, Anne C Mirabella, Tian-Li Wang, Balázs Gyorffy, Mathieu Lupien. Proc Natl Acad Sci U S A 2013
108
18

Sox2 promotes tamoxifen resistance in breast cancer cells.
Marco Piva, Giacomo Domenici, Oihana Iriondo, Miriam Rábano, Bruno M Simões, Valentine Comaills, Inmaculada Barredo, Jose A López-Ruiz, Ignacio Zabalza, Robert Kypta,[...]. EMBO Mol Med 2014
208
18

Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines.
L Gelsomino, S Panza, C Giordano, I Barone, G Gu, E Spina, S Catalano, S Fuqua, S Andò. Cancer Lett 2018
41
21

Prospective identification of tumorigenic breast cancer cells.
Muhammad Al-Hajj, Max S Wicha, Adalberto Benito-Hernandez, Sean J Morrison, Michael F Clarke. Proc Natl Acad Sci U S A 2003
16

Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.
Paola Rizzo, Haixi Miao, Gwendolyn D'Souza, Clodia Osipo, Lynda L Song, Jieun Yun, Huiping Zhao, Joaquina Mascarenhas, Debra Wyatt, Giovanni Antico,[...]. Cancer Res 2008
274
16

Biological determinants of endocrine resistance in breast cancer.
Elizabeth A Musgrove, Robert L Sutherland. Nat Rev Cancer 2009
938
14

Notch signaling: cell fate control and signal integration in development.
S Artavanis-Tsakonas, M D Rand, R J Lake. Science 1999
14

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe-Jauffret, Florence Monville, Julie Dutcher, Marty Brown, Jocelyne Jacquemier, Patrice Viens, Celina G Kleer, Suling Liu,[...]. Cell Stem Cell 2007
14

Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.
Hannah Harrison, Bruno M Simões, Lynsey Rogerson, Sacha J Howell, Göran Landberg, Robert B Clarke. Breast Cancer Res 2013
68
14


Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.
Toula Bouras, Bhupinder Pal, François Vaillant, Gwyndolen Harburg, Marie-Liesse Asselin-Labat, Samantha R Oakes, Geoffrey J Lindeman, Jane E Visvader. Cell Stem Cell 2008
331
12

Transcriptome analysis of the normal human mammary cell commitment and differentiation process.
Afshin Raouf, Yun Zhao, Karen To, John Stingl, Allen Delaney, Mary Barbara, Norman Iscove, Steven Jones, Steven McKinney, Joanne Emerman,[...]. Cell Stem Cell 2008
260
12

Aberrant activation of notch signaling in human breast cancer.
Spyros Stylianou, Rob B Clarke, Keith Brennan. Cancer Res 2006
421
12

Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
Bhuvaneswari Ramaswamy, Yuanzhi Lu, Kun-Yu Teng, Gerard Nuovo, Xiaobai Li, Charles L Shapiro, Sarmila Majumder. Cancer Res 2012
153
12

CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling.
A Dubrovska, A Hartung, L C Bouchez, J R Walker, V A Reddy, C Y Cho, P G Schultz. Br J Cancer 2012
79
12

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
12

Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch.
James M Haughian, Mauricio P Pinto, J Chuck Harrell, Brian S Bliesner, Kristiina M Joensuu, Wendy W Dye, Carol A Sartorius, Aik Choon Tan, Päivi Heikkilä, Charles M Perou,[...]. Proc Natl Acad Sci U S A 2012
80
12

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
Weiyi Toy, Yang Shen, Helen Won, Bradley Green, Rita A Sakr, Marie Will, Zhiqiang Li, Kinisha Gala, Sean Fanning, Tari A King,[...]. Nat Genet 2013
719
12

Mechanisms of aromatase inhibitor resistance.
Cynthia X Ma, Tomás Reinert, Izabela Chmielewska, Matthew J Ellis. Nat Rev Cancer 2015
234
12

Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer.
Quyen Thu Bui, Ji Hye Im, Sung Baek Jeong, Young-Mi Kim, Sung Chul Lim, Bumseok Kim, Keon Wook Kang. Cancer Lett 2017
54
12

Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Suling Liu, Yang Cong, Dong Wang, Yu Sun, Lu Deng, Yajing Liu, Rachel Martin-Trevino, Li Shang, Sean P McDermott, Melissa D Landis,[...]. Stem Cell Reports 2013
631
10

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
Ylenia Lombardo, Aleksandra Filipović, Gemma Molyneux, Manikandan Periyasamy, Georgios Giamas, Yunhui Hu, Pritesh S Trivedi, Jayson Wang, Ernesto Yagüe, Loren Michel,[...]. Proc Natl Acad Sci U S A 2012
54
10

Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin.
Kevin G Leong, Kyle Niessen, Iva Kulic, Afshin Raouf, Connie Eaves, Ingrid Pollet, Aly Karsan. J Exp Med 2007
365
10

Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition.
Ingrid Espinoza, Radhika Pochampally, Fei Xing, Kounosuke Watabe, Lucio Miele. Onco Targets Ther 2013
135
10

Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate.
Diego Raffo, Damian E Berardi, Osvaldo Pontiggia, Laura Todaro, Elisa Bal de Kier Joffé, Marina Simian. Breast Cancer Res Treat 2013
29
17

STAT3 mediates resistance of CD44(+)CD24(-/low) breast cancer stem cells to tamoxifen in vitro.
Xiaoyan Wang, Guozhu Wang, Yi Zhao, Xiaoan Liu, Qiang Ding, Jingping Shi, Yin Ding, Shui Wang. J Biomed Res 2012
37
13

Stem cells, cancer, and cancer stem cells.
T Reya, S J Morrison, M F Clarke, I L Weissman. Nature 2001
10

Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.
Rosemarie C D'Angelo, Maria Ouzounova, April Davis, Daejin Choi, Stevie M Tchuenkam, Gwangil Kim, Tahra Luther, Ahmed A Quraishi, Yasin Senbabaoglu, Sarah J Conley,[...]. Mol Cancer Ther 2015
83
10

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
Tiffany M Phillips, William H McBride, Frank Pajonk. J Natl Cancer Inst 2006
971
10

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
José Baselga, Mario Campone, Martine Piccart, Howard A Burris, Hope S Rugo, Tarek Sahmoud, Shinzaburo Noguchi, Michael Gnant, Kathleen I Pritchard, Fabienne Lebrun,[...]. N Engl J Med 2012
10

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.
X Rao, G Di Leva, M Li, F Fang, C Devlin, C Hartman-Frey, M E Burow, M Ivan, C M Croce, K P Nephew. Oncogene 2011
276
10

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
10


Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
Naoko Takebe, Lucio Miele, Pamela Jo Harris, Woondong Jeong, Hideaki Bando, Michael Kahn, Sherry X Yang, S Percy Ivy. Nat Rev Clin Oncol 2015
783
10

Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.
Nicholas J Wang, Zachary Sanborn, Kelly L Arnett, Laura J Bayston, Wilson Liao, Charlotte M Proby, Irene M Leigh, Eric A Collisson, Patricia B Gordon, Lakshmi Jakkula,[...]. Proc Natl Acad Sci U S A 2011
324
10

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
Yan Ni Loh, Ellen L Hedditch, Laura A Baker, Eve Jary, Robyn L Ward, Caroline E Ford. BMC Cancer 2013
88
10

Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
Dan R Robinson, Yi-Mi Wu, Pankaj Vats, Fengyun Su, Robert J Lonigro, Xuhong Cao, Shanker Kalyana-Sundaram, Rui Wang, Yu Ning, Lynda Hodges,[...]. Nat Genet 2013
723
10

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
10

Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.
Gabriela Dontu, Kyle W Jackson, Erin McNicholas, Mari J Kawamura, Wissam M Abdallah, Max S Wicha. Breast Cancer Res 2004
549
10

A Role for Notch Signalling in Breast Cancer and Endocrine Resistance.
Ahmet Acar, Bruno M Simões, Robert B Clarke, Keith Brennan. Stem Cells Int 2016
43
11

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.
Pedram Razavi, Matthew T Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S Ross, Neil Vasan, Yanyan Cai, Craig M Bielski, Mark T A Donoghue, Philip Jonsson,[...]. Cancer Cell 2018
402
10

Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway.
Olaf Hardt, Stefan Wild, Ilka Oerlecke, Kay Hofmann, Shujun Luo, Yvonne Wiencek, Eva Kantelhardt, Christoph Vess, Geoffrey P Smith, Gary P Schroth,[...]. Cancer Lett 2012
48
10

The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer.
David Rodriguez, Marc Ramkairsingh, Xiaozeng Lin, Anil Kapoor, Pierre Major, Damu Tang. Cancers (Basel) 2019
38
13

Generation of breast cancer stem cells through epithelial-mesenchymal transition.
Anne-Pierre Morel, Marjory Lièvre, Clémence Thomas, George Hinkal, Stéphane Ansieau, Alain Puisieux. PLoS One 2008
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.